Zambia launches $213 million vaccine plant project
By the AFREEQUE newsroom, based on Lusaka Times
Illustrative image · SHVETS production · Pexels · Licence PexelsZambia’s state-owned Industrial Development Corporation and Chinese company Jijia International Medical Technology have signed an agreement to create ZAMVAX Limited, a vaccine plant valued at $213 million. The project aims to strengthen local production and health security in Zambia, according to information presented at the signing in Lusaka.





